Get the Stockscreener App
1.77
0.00%
0.00
Pre-market:
1.74
-0.03
-1.69%
Sana Biotechnology Inc stock is traded at $1.77, with a volume of 2.30M.
It is up +0.00% in the last 24 hours and down -17.67% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$1.77
Open:
$1.75
24h Volume:
2.30M
Relative Volume:
0.63
Market Cap:
$357.79M
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-1.2041
EPS:
-1.47
Net Cash Flow:
$-273.61M
1W Performance:
+7.27%
1M Performance:
-17.67%
6M Performance:
-52.93%
1Y Performance:
-79.18%
1-Day Range:
$1.645
$1.82
1-Week Range:
$1.59
$1.91
52-Week Range:
$1.26
$10.50
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.77 | 357.79M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to - Bluefield Daily Telegraph
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Sells 110,538 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
Sana Biotechnology Inc (SANA) Stock: A Year of Decreases and Increases - investchronicle.com
Press Release Distribution & PR Platform - ACCESS Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action ... - Bluefield Daily Telegraph
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors - GlobeNewswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Sana stock holds $11 target with Buy rating at H.C. Wainwright - Investing.com India
Citizens JMP upgrades Sana Biotechnology Inc (SANA) stock to a Mkt outperform - knoxdaily.com
Class Action Filed Against Sana Biotechnology, Inc. (SANA)May 20, 2025 Deadline to Join – Contact The Gross Law Firm - TradingView
Taking on analysts’ expectations and winning: Sana Biotechnology Inc (SANA) - Sete News
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - PR Newswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TradingView
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
Lost Money on Sana Biotechnology, Inc.(SANA)? Join Class Action Suit Seeking Recovery – Contact - Bluefield Daily Telegraph
Lost Money on Sana Biotechnology, Inc.(SANA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - The Malaysian Reserve
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana ... - Bluefield Daily Telegraph
The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - PR Newswire
Is Sana Biotechnology Inc. (NASDAQ:SANA) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Sana Biotechnology, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 20, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to - Bluefield Daily Telegraph
Investors in Sana Biotechnology, Inc. Should Contact The - GlobeNewswire
Shareholders That Lost Money on Sana Biotechnology, Inc. (SANA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - Eastern Progress
SANA Investors Have the Opportunity to Lead the Sana - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
KLP Kapitalforvaltning AS Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sana Biotechnology Inc Stock (SANA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):